INTANGIBLE ASSETS (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets
Accumulated Amortization	$ (370,338)	$ (384,712)
Indefinite-Lived Intangible Assets
Gross Carrying Amount	5,058,452	4,477,391
Net Amount	4,688,114	4,092,679
Hormone Therapy Drug Candidate Patents - (Pending) [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount		1,855,279
Net Amount	1,833,584	1,855,279
Multiple Trademarks [Member]
Indefinite-Lived Intangible Assets
Gross Carrying Amount	$ 262,305	264,289
Net Amount		264,289
Domestic Utilty Patent - Opera Software [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount		31,951
Accumulated Amortization		(10,484)
Net Amount		$ 21,467
Weighted average remaining amortization period	13 years 6 months	10 years 9 months
Approved Hormone Therapy Drug Candidate Patents [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	$ 2,962,563	$ 2,234,129
Accumulated Amortization	(370,338)	(282,485)
Net Amount	$ 2,592,225	$ 1,951,644
Weighted average remaining amortization period		14 years
Development Costs Of Corporate Website [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount		$ 91,743
Accumulated Amortization		$ (91,743)